Google (GOOG) which is down a quick $100 points from its all time high. Fundamentally speaking Google couldn’t be doing better, its recent approval of DoubleClick got pasted US regulators without a hitch. Search competitor Yahoo (YHOO) is near its 52-week and is losing market share, business and clicks to Google all the time. Google makes a substantially amount of money during the holiday season as it raises its search fees and add spots for companies vying for customers. Google makes money every time someone clicks on these paid adds netting a small amount of profit each time someone searches. As we saw from Amazon online sales were great hence, Google is doing great. I have a feeling that the downside pressure that Google saw is due in part to some funds selling their stake to raise capital. With $14BB in cash and no debt, Google is growing earnings at 30% Google’s a buy.

Google (GOOG) which is down a quick $100 points from its all time high. Fundamentally speaking Google couldn’t be doing better, its recent approval of DoubleClick got pasted US regulators without a hitch. Search competitor Yahoo (YHOO) is near its 52-week and is losing market share, business and clicks to Google all the time. Google makes a substantially amount of money during the holiday season as it raises its search fees and add spots for companies vying for customers. Google makes money every time someone clicks on these paid adds netting a small amount of profit each time someone searches. As we saw from Amazon online sales were great hence, Google is doing great. I have a feeling that the downside pressure that Google saw is due in part to some funds selling their stake to raise capital. With $14BB in cash and no debt, Google is growing earnings at 30% Google’s a buy.

TER is an interesting stock—down 44% for the year this chip maker has a whopping $610 MM in cash and zero debt. Right now the chip makers are getting killed. With INTC reporting earnings this week look for TER to rally on any margin expansion news from INTC.

Manitowoc (MTW) which is a maker of international cranes and other basic construction vehicles worldwide. Recently shares of Manitowoc have moved from a high of $52 a share back on December 24th to $41 a share due in part to an inaccurate assumption that global growth was slowing. Manitowoc recently raised its 2008 guidance saying that sales at its crane division should grow by more than 20% next year and that is after seeing 100% year-over-year growth in its backlog. Here I am going with management and not the masses who are selling the stock down.

Last week Shaw Group posted record earnings of 49 cents a share added buy “Our fossil and nuclear power, and fabrication and manufacturing groups are performing well in what continues to be a robust market”—Shaw group is one of the best ways to play the global infrastructure boom. Hidden in the pres release (which the market did not pick up on) was the follow bullish statement from SGR which could push shares higher “Shaw said it expected 68 percent of the backlog to be converted to revenue over the next 24 months. The company also maintained its previous guidance for the 2007-08 fiscal year, saying it expected per-share earnings of $2.30 to $2.60 on revenue of about $7 billion)

Down 100 points from its high BIDU’s stock has been crushed ever since its CFO died in a plane crash. Recent polls show that BIDU is still the leader (and growing) in search in China with 60% of all searches used thru their engine. Look for BIDU to snapback first as the Nasdaq is extremely oversold—While, no direct catalyst, I am looking for snapback in the coming week.

Also making this week’s list is Genentech (DNA) which is set to report earnings after the close on Monday. By all accounts Genetech’s flagship drug Avastin is selling very well and should help the bottom line. With shares down 17% in 2007 this mega bio-tech company is a great defensive way to play into a turbulent market.

Merrill Lynch reports earnings this week—Look for a kitchen sink type of approach from CEO John Thain during Merrill’s call. Rumors of a $15Billion write down and capital infusion from a Chinese bank have been mentioned all last week. Look for Thain to take a very serious approach in cleaning up MER’s balance sheet. This is a play not of Merrill’s earnings (which will be bad) but rather how management hands the conference call and write down.